logo
AAT Bioquest

Dual specificity testis-specific protein kinase 1 Inhibitors (IC50, Ki)

Structure
Compound Name
Standard Type
Standard Values (in nM)
1-Ethyl-3-[5-[6-(4-methoxy-2,6-dimethylphenyl)-2-pyrazin-2-ylpyrimidin-4-yl]-1,3-thiazol-2-yl]ureaIC50455.0 [1]
CID 58688563IC5030000.0 [1]
CID 58688690IC502198.0 [1]
5-(2-Amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-N-tert-butylpyridine-3-sulfonamideIC5010000.0 [1]
6-(2,4-Difluorophenyl)sulfonyl-2-(1H-indol-5-ylamino)-8-methylpyrido[2,3-d]pyrimidin-7-oneIC5010000.0 [1]
3-Chloro-4-[6-[2-(propylamino)-1,3-thiazol-5-yl]-2-pyrazin-2-ylpyrimidin-4-yl]phenolIC5030000.0 [1]
Methyl N-[5-[6-(2,6-dimethyl-4-pentan-3-yloxyphenyl)-2-pyrazin-2-ylpyrimidin-4-yl]-1,3-thiazol-2-yl]carbamateIC5030000.0 [1]
5-[6-[2-Chloro-5-(2-cyclohexylethoxy)phenyl]-2-pyrazin-2-ylpyrimidin-4-yl]-N-propyl-1,3-thiazol-2-amineIC5030000.0 [1]
N-[5-[6-(2,6-Dimethyl-4-pentan-3-yloxyphenyl)-2-pyrazin-2-ylpyrimidin-4-yl]-1,3-thiazol-2-yl]-2-methylpropanamideIC5012500.0 [1]
Methyl N-[5-[6-(4-methoxy-2,6-dimethylphenyl)-2-pyrazin-2-ylpyrimidin-4-yl]-1,3-thiazol-2-yl]carbamateIC5011910.0 [1]
1-[5-[6-(2,6-Dichloro-4-methoxyphenyl)-2-pyrazin-2-ylpyrimidin-4-yl]-1,3-thiazol-2-yl]-3-methylureaIC5030000.0 [1]
5-[6-(2,6-Dichloro-4-pentan-3-yloxyphenyl)-2-pyrazin-2-ylpyrimidin-4-yl]-N-propyl-1,3-thiazol-2-amineIC5030000.0 [1]
5-[6-(2-Chloro-4-cyclopentyloxyphenyl)-2-pyrazin-2-ylpyrimidin-4-yl]-N-propyl-1,3-thiazol-2-amineIC5030000.0 [1]
5-[6-(2,6-Dichloro-4-methoxyphenyl)-2-pyrazin-2-ylpyrimidin-4-yl]-N-propyl-1,3-thiazol-2-amineIC5030000.0 [1]
5-[6-(2-Chloro-4-methoxyphenyl)-2-pyrazin-2-ylpyrimidin-4-yl]-N-propyl-1,3-thiazol-2-amineIC5030000.0 [1]
5-[6-(2-Chloro-4-pentan-3-yloxyphenyl)-2-pyrazin-2-ylpyrimidin-4-yl]-N-propyl-1,3-thiazol-2-amineIC5030000.0 [1]
5-[6-(2-Chloro-4-pentoxyphenyl)-2-pyrazin-2-ylpyrimidin-4-yl]-N-propyl-1,3-thiazol-2-amineIC5030000.0 [1]
5-[6-(2,6-Dichloro-4-propoxyphenyl)-2-pyrazin-2-ylpyrimidin-4-yl]-N-propyl-1,3-thiazol-2-amineIC5030000.0 [1]
N-[5-[6-(2,6-Dimethyl-4-pentan-3-yloxyphenyl)-2-pyrazin-2-ylpyrimidin-4-yl]-1,3-thiazol-2-yl]acetamideIC5030000.0 [1]
1-[5-[6-(4-Methoxy-2,6-dimethylphenyl)-2-pyrazin-2-ylpyrimidin-4-yl]-1,3-thiazol-2-yl]-3-methylureaIC501133.0 [1]
5-[6-(2-Methyl-4-pentan-3-yloxyphenyl)-2-pyrazin-2-ylpyrimidin-4-yl]-N-propyl-1,3-thiazol-2-amineIC5030000.0 [1]
5-[6-(2,6-Dichloro-4-cyclopentyloxyphenyl)-2-pyrazin-2-ylpyrimidin-4-yl]-N-propyl-1,3-thiazol-2-amineIC5030000.0 [1]
N-[5-[6-(4-Methoxy-2,6-dimethylphenyl)-2-pyrazin-2-ylpyrimidin-4-yl]-1,3-thiazol-2-yl]acetamideIC502265.0 [1]
5-[6-(2-Chloro-5-propoxyphenyl)-2-pyrazin-2-ylpyrimidin-4-yl]-N-propyl-1,3-thiazol-2-amineIC5030000.0 [1]
5-[6-(2-Chloro-5-methoxyphenyl)-2-pyrazin-2-ylpyrimidin-4-yl]-N-propyl-1,3-thiazol-2-amineIC5030000.0 [1]



References

This online tool may be cited as follows

MLA

"Quest Database™ Dual specificity testis-specific protein kinase 1 Inhibitors (IC50, Ki)." AAT Bioquest, Inc.21 Nov2024https://www.aatbio.com/data-sets/dual-specificity-testis-specific-protein-kinase-1-inhibitors-ic50-ki.

APA

AAT Bioquest, Inc. (2024November 21). Quest Database™ Dual specificity testis-specific protein kinase 1 Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/dual-specificity-testis-specific-protein-kinase-1-inhibitors-ic50-ki.
BibTeXEndNoteRefMan